Citi Opens 90-Day Positive Catalyst Watch on LENZ Therapeutics Inc (LENZ)
Tweet Send to a Friend
Citi analyst Yigal Nochomovitz reiterated a Buy rating and $45.00 price target on LENZ Therapeutics Inc (NASDAQ: LENZ).The analyst comments ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
